Paraphernalia
PPubMed7 Aug 2017Cited 145×

stageR: a general stage-wise method for controlling the gene-level false discovery rate in differential expression and differential transcript usage

Koen Van den Berge, Charlotte Soneson, Mark D. Robinson, Lieven Clement

Abstract

'Lieven Clement'] RNA sequencing studies with complex designs and transcript-resolution analyses involve multiple hypotheses per gene; however, conventional approaches fail to control the false discovery rate (FDR) at gene level. We propose stageR, a two-stage testing paradigm that leverages the increased power of aggregated gene-level tests and allows post hoc assessment for significant genes. This method provides gene-level FDR control and boosts power for testing interaction effects. In transcript-level analysis, it provides a framework that performs powerful gene-level tests while maintaining biological interpretation at transcript-level resolution. The procedure is applicable whenever individual hypotheses can be aggregated, providing a unified framework for complex high-throughput experiments. Electronic supplementary material The online version of this article (doi:10.1186/s13059-017-1277-0) contains supplementary material, which is available to authorized users.

A figure from stageR: a general stage-wise method for controlling the gene-level false discovery rate in differential expression and differential transcript usage
fig. from the paper

§ The Valyu brief

Reading the full paper and taking notes. This takes a few seconds…

§ Ask this paper

Ask a question about this paper

Valyu reads the full text and answers from what the paper actually says.

Q.

Searching the other archives…

stageR: a general stage-wise method for controlling the gene-level false discovery rate in differential expression and differential transcript usage · Paraphernalia